Table 2 |
|||||
|
Summary of results for 30 lung cancers screened for mutations in KRAS |
|||||
|
Patient |
Histology |
HRM |
Sequencing |
AA change |
EGFR sequencing |
|
|
|||||
|
1 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
2 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
3 |
Adenocarcinoma |
mut |
35G > T |
G12V |
wt |
|
4 |
Adenocarcinoma |
mut |
34G > T |
G12C |
wt |
|
5 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
6 |
Adenocarcinoma |
mut |
35G > A |
G12D |
wt |
|
7 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
8 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
9 |
Adenocarcinoma |
wt |
wt |
- |
exon 19 del |
|
10 |
Adenocarcinoma |
wt |
wt |
- |
exon 19 del |
|
11 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
12 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
13 |
Adenocarcinoma |
mut |
35G > T |
G12V |
wt |
|
14 |
Adenocarcinoma |
mut |
34G > T |
G12C |
wt |
|
15 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
16 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
17 |
Adenocarcinoma |
wt |
wt |
- |
exon 19 del |
|
18 |
Adenocarcinoma |
mut |
38G > A |
G13D |
wt |
|
19 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
20 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
21 |
Adenocarcinoma |
wt |
wt |
- |
wt |
|
22 |
Adenocarcinoma |
mut |
35G > T |
G12V |
wt |
|
23 |
Large cell |
wt |
wt |
- |
Not done |
|
24 |
Large cell |
wt |
wt |
- |
Not done |
|
25 |
Large cell |
mut |
35G > C |
G12A |
Not done |
|
26 |
Large cell |
wt |
wt |
- |
Not done |
|
27 |
Large cell |
wt |
wt |
- |
Not done |
|
28 |
Large cell |
wt |
wt |
- |
Not done |
|
29 |
Large cell |
mut |
35G > T |
G12V |
Not done |
|
30 |
Large cell |
wt |
wt |
- |
Not done |
|
|
|||||
|
HRM – high resolution melting, wt – wild-type, mut – mutant, AA change – amino acid change, exon 19 del – EGFR Exon 19 deletion |
|||||
|
Krypuy et al. BMC Cancer 2006 6:295 doi:10.1186/1471-2407-6-295 |
|||||